Stereotaxis (STXS) received U.S. Food and Drug Administration 510(k) clearance for its MAGiC Sweep catheter. The company said, “MAGiC Sweep is the world’s first robotically navigated high-density electrophysiology mapping catheter, representing a significant advancement in the technology available to diagnose and treat complex arrhythmia patients.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STXS: